An expert panel appointed by the Centre has found to its horror that fluorosis has reached epidemic proportions in Garhwa as a result of the Jharkhand government’s negligence and failure to check the alarming spread of the disease. The team, appointed by the Union ministry of drinking water and sanitation, visited the district last month and found men, women and children of all ages with deformities due to fluoride poisoning from...

As many as 56 villages in the Saranda forests, freed from over 10 years of Maoist dominance in a month-long offensive in August, is set to see a new era of development with the Centre planning to showcase it as a test case to prove that police action is no impediment to building social infrastructure. Union rural development minister Jairam Ramesh, who visited the Jharkhand capital last week, has sent a...

The Life Insurance Corporation (LIC) invested more than Rs 3,600 crore last year in the tobacco industry, anti-tobacco activists and cancer specialists said today, describing the investments as ironical and unethical. Figures obtained through the right to information route by a consortium of activists and doctors show that in 2010-11, LIC had invested in shares of ITC and VST Industries and in debentures of Dharampal Satyapal Ltd, which makes chewable tobacco...

-The Times of India   Should government-run companies invest in tobacco firms? This is the question that Voices of Tobacco Victims (VoTV), an NGO working for cancer Patients, has raised after its recent query under the RTI Act revealed that the Life Insurance Corporation of India has invested up to Rs 3,500 crore in various tobacco companies. "It's the greatest irony that the government spends Rs 10,000 crore on treatment of tobacco-related illnesses...

Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive Patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...